Zobrazeno 1 - 10
of 24
pro vyhledávání: '"H. Glanzer"'
Publikováno v:
ANZ Journal of Surgery. 67:637-639
Background: Polytetrafluoroethylene (PTFE), dacron, and, more recently, collagen prostheses are finding increasing use for femoropopliteal reconstruction when a suitable vein is not available. The main factors to be considered when choosing a prosthe
Publikováno v:
Biomedizinische Technik/Biomedical Engineering. 40:198-200
Autor:
H Glanzer, G Pierer, Gerhard Prause, Josef Smolle, Freyja-Maria Smolle-Jüttner, B Ratzenhofer-Comenda
Publikováno v:
Anaesthesia. 52(3)
This trial was designed to study the correlation between peri-operative mortality in patients undergoing elective surgery and the physical status classification of the American Society of Anesthesiologists, the Goldman multifactorial cardiac risk ind
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 21(6)
Forty-eight patients with non-resectable cancer of the oesophagus and oesophagogastric junction (Group A: Stage I/II, 32; Group B: Stage III/IV, 16) underwent intraluminal Iridium-192 high dose-rate afterloading therapy (5-7 Gy/session, total dose: 5
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 20(6)
A group of 79 patients with non-resectable lung carcinomas (T1, 1; T2, 13; T3, 34; T4, 19; recurrence, 12) underwent endobronchial iridium-192 high-dose rate afterloading therapy (5 Gy/session total dose: 5-25 Gy, mean 11.6 Gy). In 39 cases the fair
Publikováno v:
Biomedizinische Technik/Biomedical Engineering. 41:132-133
Publikováno v:
Biomedizinische Technik/Biomedical Engineering. 41:428-429
Publikováno v:
Biomedizinische Technik/Biomedical Engineering. 38:447-448
Publikováno v:
European Journal of Cancer. 31:S184
Local tumor control is considered worthwhile in patients with advanced malignant disease to improve quality of life, though there is no effect on survival. MWHT in combination with radiotherapy or chemotherapy is able to improve remission rates of ra
Publikováno v:
Radiotherapy and Oncology. 31:S47